Syndax Pharmaceuticals Now on VARA Pro
Syndax Pharmaceuticals, a commercial-stage oncology innovator with two first-in-class products, has made its consensus estimates accessible on VARA Pro.
How to Build a Stock Portfolio and Avoid Social Media Fakes
Michael Vara’s Column: How to Build a Stock Portfolio and Avoid Social Media Fakes
Ukraine, Trump, and Market Moves: What 2025 Might Bring
Michael Vara’s Column: Ukraine, Trump, and Market Moves: What 2025 Might Bring
Stock Investing: One of the Best Life Coaches
Michael Vara’s Column: Stock Investing: One of the Best Life Coaches
Should Cities Invest in Stocks? Kurikka Thinks So
Michael Vara’s Column: Should Cities Invest in Stocks? Kurikka thinks so
Anora Group’s Consensus Now Available on VARA Pro
VARA News Anora Group's Consensus Now Available On VARA Pro
Signals From VARA Pro Q2/2024
This review outlines how our clients performed during the second quarter of 2024.
Announcement: Rebranding to VARA
Vara Research has rebranded to VARA, ushering in a new era of innovation and excellence.